A novel CXCL8-IP10 hybrid protein is effective in blocking pulmonary pathology in a mouse model of Klebsiella pneumoniae infection
Author:
Funder
National Science Foundation of China
Ministry of Science and Technology of Taiwan
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference38 articles.
1. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance;Pitout;Antimicrob. Agents Chemother.,2015
2. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Munoz-Price;Lancet Infect. Dis.,2013
3. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria;Olaitan;Front. Microbiol.,2014
4. Extracellular DNA and histones: double-edged swords in immunothrombosis;Gould;J. Thromb. Haemost.,2015
5. Inflammation and regeneration in the dentin-pulp complex: a double-edged sword;Cooper;J. Endod.,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Omics-based Analysis of Bhadradarvadi Kashayam in Managing Rheumatoid Arthritis via CXCL8-CXCR1/2 axis, MAPK and NF-κB Signaling Pathways - A Network Pharmacology Approach;Biomedical and Pharmacology Journal;2024-06-25
2. Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis;2024-02-14
3. IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa;Life Science Alliance;2022-06-21
4. CXCL8 chemokine in ulcerative colitis;Biomedicine & Pharmacotherapy;2021-06
5. A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma;OncoTargets and Therapy;2019-09
A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3